Exosome Diagnostics, Inc. is focused on commercializing proprietary genetics based diagnostics in oncology and endocrinology.
Exosome derived RNA testing has the potential to improve the diagnosis of new cancers, identify the occurrence of post-operative cancers and more precisely monitor the efficacy of drug therapies.
